Thangavelu Saravanan

Thangavelu Saravanan

Active Director Director DIN 08325439
DIN 08325439 First appointment Jan 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Jan 2019
Shareholding value •••• Premium profile

About Thangavelu Saravanan

Data last updated:

Thangavelu Saravanan is a Director at Abirami Kidney Care Private Limited (since 2019), Director at Sree Ss Pharma Private Limited (since 2019) and Director at Four Square Medical Centre And Hospital Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹20.71 Cr; the largest is Abirami Kidney Care Private Limited at ₹11.63 Cr (FY 2025).

DIN 08325439
Primary Designation Director
Industry Healthcare
First Appointment 09 Jan 2019
Oldest Company Age 12 yrs
Largest company Abirami Kidney Care Private Limited · ₹11.63 Cr (FY 2025)
Combined revenue ₹20.71 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abirami Kidney Care Private Limited U93000TZ2019PTC031494
Director09 Jan 20192019₹11.63 Cr (FY 2025)Active
Sree Ss Pharma Private Limited U51909TZ2019PTC033203
Director24 Dec 20192019₹7.51 Cr (FY 2025)Active
Director30 Aug 20212021₹1.58 Cr (FY 2025)Active
Director03 Apr 20252025Active
Partner30 Sep 20232014Active

Directorship timeline

Open interactive timeline →
Sree Ss Pharma Private Limited
Four Square Medical Centre And Hospital Private Limited
Abirami Kidney Care Private Limited
Sri Lalitham Realty Services Private Limited
Premium access

Shareholding and investment profile for Thangavelu Saravanan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thangavelu Saravanan

Thangavelu Saravanan currently holds 5 directorships: Abirami Kidney Care Private Limited (Director, since 09 Jan 2019, revenue ₹11.63 Cr (FY 2025)); Sree Ss Pharma Private Limited (Director, since 24 Dec 2019, revenue ₹7.51 Cr (FY 2025)); Four Square Medical Centre And Hospital Private Limited (Director, since 30 Aug 2021, revenue ₹1.58 Cr (FY 2025)); Sri Lalitham Realty Services Private Limited (Director, since 03 Apr 2025); Karur Doctors Pharma Llp (Partner, since 30 Sep 2023).

Thangavelu Saravanan was first appointed on 09 Jan 2019 as Director at Abirami Kidney Care Private Limited. The most recent appointment on record is 03 Apr 2025 at Sri Lalitham Realty Services Private Limited.

The 3 current companies of Thangavelu Saravanan that report revenue have a combined latest revenue of ₹20.71 Cr: Abirami Kidney Care Private Limited ₹11.63 Cr (FY 2025); Sree Ss Pharma Private Limited ₹7.51 Cr (FY 2025); Four Square Medical Centre And Hospital Private Limited ₹1.58 Cr (FY 2025).

The current boards of Thangavelu Saravanan's companies include Jambai Munirajah Jayaprakash (Abirami Kidney Care Private Limited), Thangavelu Kalavathi (Abirami Kidney Care Private Limited), Chidambaram Natarajan Raman (Karur Doctors Pharma Llp), Elango Ravirajasekar (Karur Doctors Pharma Llp), Kulandaiappan Chellappan Balasubramaniam (Karur Doctors Pharma Llp), Manohar Rajalingam (Karur Doctors Pharma Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available